AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford–AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden and Gaithersburg in Maryland, U.S. AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index.

Read more in the app

AstraZeneca unveils successes in treatment of lung cancer

Lung cancer deaths cut in half with AstraZeneca pill

British Man Died of Rare Blood Syndrome Linked to AstraZeneca’s Vaccine

British Man Died of Rare Blood Syndrome Linked to AstraZeneca’s Vaccine

AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows

Is the team behind the Oxford-AstraZeneca vaccine on the brink of defeating malaria?

Increase in Guillain-Barré Syndrome Following AstraZeneca COVID-19 Vaccine

Independent Studies Find Elevated Risk of Blood Clots in the Brain Following AstraZeneca COVID-19 Vaccination

AstraZeneca jab criticism ‘probably killed hundreds of thousands,’ claims scientist

British Medical Journal: "unacceptable delay" in the release of participant level data from Pfizer/Moderna/AstraZeneca vaccine trials.

First-of-Its-Kind Drug Cuts Risk of Severe COVID-19 in Half, AstraZeneca Says

Covid-19 news: UK approves Pfizer and AstraZeneca booster shots

AstraZeneca Scientist Says Delta Variant Makes Herd Immunity Impossible. Here's Why

No Increased Risk Of Blood Clotting After Second AstraZeneca Shot, Study Finds

Blood Clots Related to AstraZeneca/Oxford COVID-19 Vaccine Can Be Treated With Early Detection

Interview: The women behind the Oxford/AstraZeneca covid-19 vaccine

Blood clots related to AstraZeneca/Oxford vaccine can be mitigated with early detection

AstraZeneca Shots Carry Slightly Higher Risk of Bleeding Problem, New Study Says

AstraZeneca covid-19 vaccine may hinder blood clotting in rare cases

Pfizer and AstraZeneca ‘highly effective’ against India Covid variant